Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In Thrombosis
Thrombosis for May/June 2018
Poor adherence to DOAC therapy requires attention, Lakkireddy D et al. Heart Rhythm 2018, Abstract B-LBCT02-03.
Sepsis-related coagulopathy and in-hospital death risk, Lyons PG et al. Crit Care Med. 2018 May;46(5):73642.
New cancer drugs linked to fewer arrhythmias, Nickel A et al. annual meeting of the American College of Cardiology ACC 18, Abstract #900-06.
Increase kidney function monitoring if INR exceeds 4.0, Traquair H et al. biennial summit of the Thrombosis & Hemostasis Societies of North America 2018, Poster 79.
Thrombosis for March/April 2018
2 approaches to diagnosing heparin-induced thrombocytopenia, Pishko A et al. Biennial summit of the Thrombosis & Hemostasis Societies of North America (THSNA) 2018, Abstract 103
VTE prophylaxis unaddressed in acutely ill patients, Amin A et al. The biennial summit of the Thrombosis & Hemostasis Societies of North America 2018, Poster 51.
Warfarin users take 10 other drugs on average, Jacobson A et al. The biennial summit of the Thrombosis & Hemostasis Societies of North America 2018. Poster 2
LVADs as destination therapy, Mehra MR et al. New Engl J Med DOI: 10.1056/NEJMoa1800866.
Thrombosis for November/December 2017
Guideline on Preventing VTE in Pediatric Cancer, J Thromb Haemost; ePub 2017 Nov 27; Tullius, et al
Thrombosis for September/October 2017
Cochrane on Anticoagulants in Patients with Cancer, Cochrane; 2017 Sep 11; Akl, Kahale, Hakoum, et al
This Newly-Tested Tool Predicts PICC-DVT Risk, J Thromb Haemost; ePub 2017 Sep 13; Chopra, et al
Gender and Survival in Patients with ET, Am J Hematol; ePub 2017 Aug 28; Tefferi, et al
Thrombosis for July/August 2017
Algorithm for Heparin-Induced Thrombocytopenia, J Thromb Haemost; ePub 2017 Jul 17; Raschke, et al